{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:05:11Z","timestamp":1790795111607,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T00:00:00Z","timestamp":1139875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2006,4,27]]},"DOI":"10.1007\/s11010-005-9053-y","type":"journal-article","created":{"date-parts":[[2006,2,13]],"date-time":"2006-02-13T14:06:43Z","timestamp":1139839603000},"page":"35-50","source":"Crossref","is-referenced-by-count":85,"title":["Peroxisome proliferator-activated receptor-\u03b1 selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice"],"prefix":"10.1007","volume":"285","author":[{"given":"Rai Ajit K.","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Jahagirdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Bisgaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,2,14]]},"reference":[{"key":"9053_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.med.56.082103.104751","volume":"56","author":"DE Moller","year":"2005","unstructured":"Moller DE, Kaufman KD: Metabolic syndrome: A clinical and molecular perspective. Annual Review of Medicine 56: 45\u201362, 2005","journal-title":"Annual Review of Medicine"},{"key":"9053_CR2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.1995.75.3.473","volume":"75","author":"GM Reaven","year":"1995","unstructured":"Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473\u2013486, 1995","journal-title":"Physiol Rev"},{"key":"9053_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1568013043357806","volume":"4","author":"N Srivastava RAK Srivastava","year":"2004","unstructured":"Srivastava RAK Srivastava N: Search for obesity drugs: targeting central and peripheral pathways. Curr Med Chem- Immunol, Endo & Met Ag 4: 75\u201390, 2004","journal-title":"Curr Med Chem- Immunol, Endo & Met Ag"},{"key":"9053_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ahj.2004.03.037","volume":"148","author":"PO Szapary","year":"2004","unstructured":"Szapary PO, Rader DJ: The triglyceride-high-density lipoprotein axis: an important target of therapy? Am Heart J 148: 211\u2013221, 2004","journal-title":"Am Heart J"},{"key":"9053_CR5","doi-asserted-by":"crossref","unstructured":"Sowers JR, Epstein M, Frohlich ED: Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37: 1053\u20131059, 2001","DOI":"10.1161\/01.HYP.37.4.1053"},{"key":"9053_CR6","doi-asserted-by":"crossref","unstructured":"Norhammar A, Malmberg K, Diderholm E, Lagerqvist B, Lindahl B, Ryden L, Wallentin L: Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43(4): 585\u2013591, 2004","DOI":"10.1016\/j.jacc.2003.08.050"},{"key":"9053_CR7","first-page":"1088","volume":"4","author":"R Candido","year":"2003","unstructured":"Candido R, Srivastava P, Cooper ME, Burrell LM: Diabetes mellitus: a cardiovascular disease. Curr Opin Investig Drugs 4: 1088\u20131094, 2003","journal-title":"Curr Opin Investig Drugs"},{"key":"9053_CR8","doi-asserted-by":"crossref","unstructured":"Rubins HB: Triglycerides and coronary heart disease: implications of recent clinical trials. J Cardiovasc Risk 7: 339\u2013345, 2000 (Review)","DOI":"10.1177\/204748730000700507"},{"key":"9053_CR9","doi-asserted-by":"crossref","unstructured":"George Steiner and Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 357: 905\u2013910, 2001","DOI":"10.1016\/S0140-6736(00)04209-4"},{"key":"9053_CR10","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1046\/j.1462-8902.2003.0310.x","volume":"1","author":"AJ Krentz","year":"2003","unstructured":"Krentz AJ: Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab Suppl 1: S19\u201327, 2003","journal-title":"Diabetes Obes Metab Suppl"},{"key":"9053_CR11","doi-asserted-by":"crossref","unstructured":"Reaven G, Abbasi F, McLaughlin T: Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 59: 207\u2013223, 2004 (Review)","DOI":"10.1210\/rp.59.1.207"},{"key":"9053_CR12","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI200421341","volume":"114","author":"K Kotani","year":"2004","unstructured":"Kotani K, Peroni OD, Minokoshi Y, Boss O, Kahn BB: GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J Clin Invest 114: 1666\u20131675, 2004","journal-title":"J Clin Invest"},{"key":"9053_CR13","doi-asserted-by":"crossref","unstructured":"Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF: Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med 11: 170\u2013176, 2001 (Review)","DOI":"10.1016\/S1050-1738(01)00084-6"},{"key":"9053_CR14","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1074\/jbc.275.12.8416","volume":"275","author":"C Taghibiglou","year":"2000","unstructured":"Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K: Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275: 8416\u20138425, 2000","journal-title":"J Biol Chem"},{"key":"9053_CR15","doi-asserted-by":"crossref","unstructured":"Fazio S, Linton MF: The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy. Curr Atheroscler Rep 6: 148\u2013157, 2004 (Review)","DOI":"10.1007\/s11883-004-0104-8"},{"key":"9053_CR16","first-page":"585","volume":"225","author":"H Duez","year":"2004","unstructured":"Duez H, Lefebvre B, Poulain P, Pineda Torra I, Percevault F, Luc G, Peters JM, Gonzalez FJ, Gineste R, Helleboid S, Fruchart JC, Fievet C, Lefebvre P, Staels B: Regulation of human ApoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor \u03b1 modulation. Arterioscler Thromb Vasc Biol 225: 585\u2013591, 2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9053_CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2337\/diabetes.51.2.276","volume":"51","author":"B Huang","year":"2002","unstructured":"Huang B, Wu P, Bowker-Kinley MM, Harris RA: Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes 51: 276\u2013283, 2002","journal-title":"Diabetes"},{"key":"9053_CR18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1194\/jlr.M300239-JLR200","volume":"45","author":"KS Frederiksen","year":"2004","unstructured":"Frederiksen KS, Wulff EM, Sauerberg P, Mogensen JP, Jeppesen L, Fleckner J: Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profiles. J Lipid Res 45: 592\u2013601, 2004","journal-title":"J Lipid Res"},{"key":"9053_CR19","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1210\/endo.142.10.8446","volume":"142","author":"C Son","year":"2001","unstructured":"Son C, Hosoda K, Matsuda J, Fujikura J, Yonemitsu S, Iwakura H, Masuzaki H, Ogawa Y, Hayashi T, Itoh H, Nishimura H, Inoue G, Yoshimasa Y, Yamori Y, Nakao K: Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes. Endocrinology 142: 4189\u20134194, 2001","journal-title":"Endocrinology"},{"key":"9053_CR20","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2337\/diabetes.52.9.2249","volume":"52","author":"KS Frederiksen","year":"2003","unstructured":"Frederiksen KS, Wulff EM, Sauerberg P, Mogensen JP, Jeppesen L, Fleckner J: Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis. Diabetes 52: 2249\u20132259, 2003","journal-title":"Diabetes"},{"key":"9053_CR21","doi-asserted-by":"crossref","first-page":"16638","DOI":"10.1074\/jbc.275.22.16638","volume":"275","author":"M Guerre-Millo","year":"2000","unstructured":"Guerre-Millo M, Gervois P, Raspe E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK, Staels B: Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275: 16638\u201316642, 2000","journal-title":"J Biol Chem"},{"key":"9053_CR22","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/diabetes.50.12.2809","volume":"50","author":"M Guerre-Millo","year":"2001","unstructured":"Guerre-Millo M, Rouault C, Poulain P, Andre J, Poitout V, Peters JM, Gonzalez FJ, Fruchart JC, Reach G, Staels B: PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50: 2809\u20132814, 2001","journal-title":"Diabetes"},{"key":"9053_CR23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","volume":"106","author":"AC Li","year":"2000","unstructured":"Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK: Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106: 523\u2013531, 2000","journal-title":"J Clin Invest"},{"key":"9053_CR24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.metabol.2003.12.010","volume":"53","author":"S Jeong","year":"2004","unstructured":"Jeong S, Kim M, Han M, Lee H, Ahn J, Kim M, Song YH, Shin C, Nam KH, Kim TW, Oh GT, Yoon M: Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice. Metabolism 53: 607\u2013613, 2004","journal-title":"Metabolism"},{"key":"9053_CR25","doi-asserted-by":"crossref","unstructured":"Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL: Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 90(5): 1889\u20131900, 1992","DOI":"10.1172\/JCI116066"},{"key":"9053_CR26","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/S0022-2275(20)41090-9","volume":"36","author":"S Haubenwallner","year":"1995","unstructured":"Haubenwallner S, Essenburg AD, Barnett BC, Pape ME, DeMattos RB, Krause BR, Minton LL, Auerbach BJ, Newton RS, Leff T, et al.: Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action. J Lipid Res 36: 2541\u20132551, 1995","journal-title":"J Lipid Res"},{"key":"9053_CR27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/bj2980409","volume":"298","author":"B Frenkel","year":"1994","unstructured":"Frenkel B, Bishara-Shieban J, Bar-Tana J: The effect of beta,beta\u2032-tetramethylhexadecane-dioic acid (MEDICA 16) on plasma very-low-density lipoprotein metabolism in rats: role of apolipoprotein C-III. Biochem J 298: 409\u2013414, 1994","journal-title":"Biochem J"},{"key":"9053_CR28","unstructured":"Bisgaier CL, Essenburg AD, Barnett BC, Auerbach BJ, Haubenwallner S, Leff T, White AD, Creger P, Pape ME, Rea TJ, Newton RS: A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor. J Lipid Res 39: 17\u201330, 1998. Erratum in: J Lipid Res 39: 1317, 1998"},{"key":"9053_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2760(91)90151-7","volume":"1086","author":"RAK Srivastava","year":"1991","unstructured":"Srivastava RAK, Jiao S, Tang J, Pfleger B, Kitchens T, Schonfeld G: In vivo regulation of LDL receptor and apoB gene expressions in inbred strains of mice by dietary fatty acids and cholesterol. Biochim Biophys Acta 1086: 29\u201343, 1991","journal-title":"Biochim Biophys Acta"},{"key":"9053_CR30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0005-2760(92)90053-X","volume":"1125","author":"RAK Srivastava","year":"1992","unstructured":"Srivastava RAK, Tang J, Krul ES, Pfleger B, Kitchens RT, Schonfeld G: Dietary fatty acids and cholesterol differ in their effects on the in vivo regulation of apoAI and apoAII gene expressions in inbred strains of mice. Biochim Biophys Acta 1125: 251\u2013261, 1992","journal-title":"Biochim Biophys Acta"},{"key":"9053_CR31","doi-asserted-by":"crossref","unstructured":"Ojeda MO, van't Veer C, Fernandez Ortega CB, Arana Rosainz Mde J, Buurman WA: Inflamm Res 54: 74\u201381, 2005","DOI":"10.1007\/s00011-004-1326-5"},{"key":"9053_CR32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1007030531478","volume":"202","author":"RAK Srivastava","year":"1999","unstructured":"Srivastava RAK, Toth L, Srivastava N, Maeda N, Schonfeld G: Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoB. Mol Cell Biochem 202: 37\u201346, 1999","journal-title":"Mol Cell Biochem"},{"key":"9053_CR33","first-page":"103","volume":"86","author":"RAK Srivastava","year":"1998","unstructured":"Srivastava RAK: Analysis of RNA by Northern blotting using riboprobes. Methods in Molecular Biology 86: 103\u2013112, 1998","journal-title":"Methods in Molecular Biology"},{"key":"9053_CR34","doi-asserted-by":"crossref","first-page":"33360","DOI":"10.1074\/jbc.272.52.33360","volume":"272","author":"RAK Srivastava","year":"1997","unstructured":"Srivastava RAK, Srivastava N, Maurizio A, Lin RC, Korach K, Lubahn D, Schonfeld G: Regulation of apolipoprotein E gene expression by estrogen occurs by translational mechanism via estrogen receptor mediated pathway. J Biol Chem 272: 33360\u201333366, 1997","journal-title":"J Biol Chem"},{"key":"9053_CR35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0008-6363(02)00492-3","volume":"55","author":"WJ Zhang","year":"2002","unstructured":"Zhang WJ, Frei B: Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res 55: 820\u2013829, 2002","journal-title":"Cardiovasc Res"},{"key":"9053_CR36","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/meta.2001.27202","volume":"200150","author":"D Kramer","year":"2001","unstructured":"Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM: Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Metabolism 200150: 1294\u20131300, 2001","journal-title":"Metabolism"},{"key":"9053_CR37","doi-asserted-by":"crossref","unstructured":"Werner AL: Travaglini MTA review of rosiglitazone in type 2 diabetes mellitus. Pharmacotherapy 21: 1082\u201399, 2001 (Review)","DOI":"10.1592\/phco.21.13.1082.34615"},{"key":"9053_CR38","doi-asserted-by":"crossref","first-page":"21805","DOI":"10.1074\/jbc.C000275200","volume":"275","author":"JH Miyake","year":"2000","unstructured":"Miyake JH, Wang SL, Davis RA: Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylas e, J Biol Chem 275: 21805\u201321808, 2000","journal-title":"J Biol Chem"},{"key":"9053_CR39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jn\/134.5.1013","volume":"134","author":"JS Choi","year":"2004","unstructured":"Choi JS, Choi YJ, Park SH, Kang JS, Kang YH: Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B. J Nutr 134: 1013\u20131019, 2004","journal-title":"J Nutr"},{"key":"9053_CR40","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1126\/science.1072891","volume":"296","author":"NL Urizar","year":"2002","unstructured":"Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y, Gonzalez FJ, Heyman RA, Mangelsdorf DJ, Moore DD: A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 296: 1703\u20131706, 2002","journal-title":"Science"},{"key":"9053_CR41","first-page":"E207","volume":"282","author":"SA Schreyer","year":"2002","unstructured":"Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC: LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol 282: E207\u2013E214, 2002","journal-title":"Am J Physiol"},{"key":"9053_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2003.07.010","volume":"171","author":"SA Schreyer","year":"2003","unstructured":"Schreyer SA, Lystig TC, Vick CM, LeBoeuf RC: Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity. Atherosclerosis 171: 49\u201355, 2003","journal-title":"Atherosclerosis"},{"key":"9053_CR43","doi-asserted-by":"crossref","first-page":"48051","DOI":"10.1074\/jbc.M206966200","volume":"277","author":"H Duez","year":"2002","unstructured":"Duez H, Chao YS, Hernandez M, Torpier G, Poulain P, Mundt S, Mallat Z, Teissier E, Burton CA, Tedgui A, Fruchart JC, Fievet C, Wright SD, Staels B: Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice. J Biol Chem 277: 48051\u201348057, 2002","journal-title":"J Biol Chem"},{"key":"9053_CR44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0014-5793(01)02146-9","volume":"491","author":"FP Mancini","year":"2001","unstructured":"Mancini FP, Lanni A, Sabatino L, Moreno M, Giannino A, Contaldo F, Colantuoni V, Goglia F: Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Lett 491: 154\u2013158, 2001","journal-title":"FEBS Lett"},{"key":"9053_CR45","doi-asserted-by":"crossref","unstructured":"Schwartz S, Raskin P, Fonseca V, Graveline JF: Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group. (1998) N Eng J Med 338: 861\u2013866, 1998","DOI":"10.1056\/NEJM199803263381302"},{"key":"9053_CR46","doi-asserted-by":"crossref","unstructured":"Linden D, Lindberg K, Oscarsson J, Claesson C, Asp L, Li L, Gustafsson M, Boren J, Olofsson SO: Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. J Biol Chem 277: 23044\u201323053, 202, 2002","DOI":"10.1074\/jbc.M110416200"},{"key":"9053_CR47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1677\/jme.0.0300317","volume":"30","author":"KS Frederiksen","year":"2003","unstructured":"Frederiksen KS, Wulf EM, Wassermann K, Sauerberg P, Fleckner J: Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists. J Mol Endocrinol 30: 317\u2013329, 2003","journal-title":"J Mol Endocrinol"},{"key":"9053_CR48","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1194\/jlr.M400009-JLR200","volume":"45","author":"JR Goudriaan","year":"2004","unstructured":"Goudriaan JR, Espirito Santo SM, Voshol PJ, Teusink B, van Dijk KW, van Vlijmen BJ, Romijn JA, Havekes LM, Rensen PC: The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J Lipid Res 45: 1475\u20131481, 2004","journal-title":"J Lipid Res"},{"key":"9053_CR49","doi-asserted-by":"crossref","first-page":"38870","DOI":"10.1074\/jbc.M106219200","volume":"276","author":"S Cases","year":"2001","unstructured":"Cases S, Stone SJ, Zhou P, Yen E, Tow B, Lardizabal KD, Voelker T, Farese RV, Jr: Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 276: 38870\u201338876, 2001","journal-title":"J Biol Chem"},{"key":"9053_CR50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00041433-199806000-00008","volume":"9","author":"BH Goodpaster","year":"1998","unstructured":"Goodpaster BH, Kelley DE: Role of muscle in triglyceride metabolism. Curr Opin Lipidol 9: 231\u2013236, 1998","journal-title":"Curr Opin Lipidol"},{"key":"9053_CR51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2337\/diabetes.50.2.411","volume":"50","author":"JM Ye","year":"2001","unstructured":"Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW: Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 50: 411\u2013417, 2001","journal-title":"Diabetes"},{"key":"9053_CR52","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409\u20132415, 1995","journal-title":"J Clin Invest"},{"key":"9053_CR53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","volume":"59","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 59: 87\u201391, 1993","journal-title":"Science"},{"key":"9053_CR54","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","volume":"393","author":"B Staels","year":"1998","unstructured":"Staels B, Koenig W, Habib A, Merval R, Lebret M, Pineda Torra I, Delerive P, Fadel A, Chinetti G, Fruchart J -C, Najib J, Maclouf J, Tedgui A: Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393: 790\u2013793, 1998","journal-title":"Nature"},{"key":"9053_CR55","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1042\/bj20030105","volume":"373","author":"T Fu","year":"2003","unstructured":"Fu T, Kashireddy P, Borensztajn J: The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E. Biochem J 373: 941\u2013947, 2003","journal-title":"Biochem J"},{"key":"9053_CR56","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1172\/JCI18730","volume":"114","author":"AC Li","year":"2004","unstructured":"Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, Valledor AF, Davis RA, Willson TM, Witztum JL, Palinski W, Glass CK: Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta\/delta, and gamma. J Clin Invest 114: 1564\u20131576, 2004","journal-title":"J Clin Invest"},{"key":"9053_CR57","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.ATV.0000143933.20616.1b","volume":"24","author":"L Branen","year":"2004","unstructured":"Branen L, Havgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S: Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscl Thromb Vasc Biol 24: 2137\u20132142, 2004","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"9053_CR58","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI11871","volume":"107","author":"MI Cybulsky","year":"2001","unstructured":"Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, IIyama M, Davis V, Gutrerrez-Ramos J, Connelly PW, Milstone DS: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107: 1255\u20131262, 2001","journal-title":"J Clin Invest"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-005-9053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-005-9053-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-005-9053-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T21:08:09Z","timestamp":1627074489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-005-9053-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,14]]},"references-count":58,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,4,27]]}},"alternative-id":["9053"],"URL":"https:\/\/doi.org\/10.1007\/s11010-005-9053-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,14]]}}}